Connacht Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $217K | Sell |
7,295
-5,111
| -41% | -$152K | 1.29% | 43 |
|
|
2023
Q2 | $224K | Sell |
12,406
-985
| -7% | -$17.8K | 0.31% | 60 |
|
|
2023
Q1 | $215K | Buy |
13,391
+1,054
| +9% | +$16.9K | 0.09% | 73 |
|
|
2022
Q4 | $226K | Sell |
12,337
-2,786
| -18% | -$51K | 0.1% | 69 |
|
|
2022
Q3 | $297K | Buy |
15,123
+3,842
| +34% | +$75.5K | 0.21% | 61 |
|
|
2022
Q2 | $210K | Buy |
+11,281
| New | +$210K | 0.09% | 89 |
|